Invention Grant
US09125932B2 Composition comprising herbal extracts or fermented products thereof having lactic acid bacteria for preventing or treating respiratory diseases
有权
包含含有用于预防或治疗呼吸系统疾病的乳酸菌的草药提取物或其发酵产物的组合物
- Patent Title: Composition comprising herbal extracts or fermented products thereof having lactic acid bacteria for preventing or treating respiratory diseases
- Patent Title (中): 包含含有用于预防或治疗呼吸系统疾病的乳酸菌的草药提取物或其发酵产物的组合物
-
Application No.: US14122950Application Date: 2012-05-30
-
Publication No.: US09125932B2Publication Date: 2015-09-08
- Inventor: Jin Yeul Ma , Dong Seon Kim , Min Cheol Yang , Jong Hyun Yoon
- Applicant: Jin Yeul Ma , Dong Seon Kim , Min Cheol Yang , Jong Hyun Yoon
- Applicant Address: KR Daejeon
- Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
- Current Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
- Current Assignee Address: KR Daejeon
- Agency: Merchant & Gould P.C.
- Priority: KR10-2011-0051653 20110530
- International Application: PCT/KR2012/004233 WO 20120530
- International Announcement: WO2012/165843 WO 20121206
- Main IPC: A61K36/00
- IPC: A61K36/00 ; A61K36/725 ; A61K36/355 ; A61K36/484 ; A61K36/489 ; A61K36/185 ; A61K36/232 ; A61K36/28 ; A61K36/704 ; A61K35/744 ; A61K36/23 ; A61K36/25 ; A61K36/634 ; A61K36/78

Abstract:
The present invention relates to a composition for preventing or treating respiratory diseases, and more particularly, to a pharmaceutical composition, and to a health food, comprising extracts of herbal mixtures or fermented products thereof having lactic acid bacteria as effective ingredients for preventing or treating respiratory diseases, wherein the herbal mixtures comprise: Sophora flavascens, Radix glycyrrhizae, Flos Lonicerae, Angelicae Gigantis radix, Aralia continentalis, Inula helenium, Saposhnikoviae radix, Zizyphus spinosa, Houttuynia cordata, Forsythiae fructus, Arctium lappa, Herba epimedii, ginseng, Lithospermi radix, Sanguisorbae radix, Cnidii rhizoma, Scrophulariae radix, and Polygoni cuspidati radix. The herbal extracts or fermented products thereof having lactic acid bacteria exhibit the effects of significantly lowering an airway resistance value; reducing the numbers of leukocytes, neutrophilic leukocytes, lymphocytes, eosinocytes, and basophil leukocytes to levels similar to that of a normal group; and reducing the infiltration of inflammatory cells and eosinocyte cells near AHR on lung tissues. Therefore, the herbal extracts or fermented products thereof having lactic acid bacteria may be valuably used for the prevention and/or treatment of respiratory diseases such as asthma.
Public/Granted literature
Information query